Publications by authors named "Kazuo Nishimura"

Claim this Profile
T
Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: a single-institution analysis.
Yasutomo Nakai, Shunki Nakagawa, Yutaka Kurahashi, Shu Okamoto, Yuichiro Nakamura, Kazuo Nishimura

Int J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events in Testicular Cancer Survivors Using EORTC QLQ-TC26: A Multi-Institutional, Cross-Sectional Study in Japan.
Takuro Goto, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Kazuo Nishimura

Int J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erdafitinib versus Chemotherapy in Fibroblast Growth Factor Receptor-Altered Advanced or Metastatic Urothelial Cancer After Progression on Anti-programmed Death-(Ligand) 1 Therapy: An Exploratory Analysis of the Asian Subpopulation in the THOR Phase 3 Study.
Nobuaki Matsubara, Yohann Loriot, Earle F Burgess, Se Hoon Park, Robert A Huddart, Kazuo Nishimura

Clin Genitourin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis.
Mototsugu Oya, Jae Young Joung, Ji Youl Lee, Mikio Sugimoto, Young Deuk Choi, Kazuo Nishimura

Cancer Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 Study.
Se Hoon Park, Yen-Hwa Chang, Jae Lyun Lee, Toni K Choueiri, Go Kimura, Kazuo Nishimura

Cancer Res Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk assessment of late biochemical recurrence after radical prostatectomy: Usefulness of ultra-sensitive prostate-specific antigen measurement.
Norihiko Kawamura, Masashi Nakayama, Takuji Hayashi, Akira Nagahara, Yasutomo Nakai, Kazuo Nishimura

Int J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities in Japanese testicular cancer survivors: A multi-institutional, cross-sectional study.
Juntaro Koyama, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Kazuo Nishimura

Int J Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis.
Nobuaki Matsubara, Hideaki Miyake, Hiroji Uemura, Atsushi Mizokami, Hiroaki Kikukawa, Kazuo Nishimura

Cancer Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.
Akihiro Yoshimura, Taigo Kato, Yasutomo Nakai, Masao Tsujihata, Shingo Toyoda, Kensaku Nishimura, Kazuo Nishimura

Int J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.
Kei Kunimasa, Naotoshi Sugimoto, Tomoyuki Yamasaki, Yoji Kukita, Fumie Fujisawa, Kazuo Nishimura

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab.
Akihiro Yoshimura, Akira Nagahara, Yu Ishizuya, Yoshiyuki Yamamoto, Koji Hatano, Kazuo Nishimura

Clin Exp Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan.
Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura

Future Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy.
Norihiko Kawamura, Takuji Hayashi, Akira Nagahara, Yasutomo Nakai, Masashi Nakayama, Kazuo Nishimura

Jpn J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy.
Akihiro Yoshimura, Yoshiyuki Yamamoto, Tatsuya Nishikawa, Masashi Fujita, Takako Inoue, Kazuo Nishimura

Int Cancer Conf J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Juntaro Koyama, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Kazuo Nishimura

Int J Urol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.
Taigo Kato, Satoru Yumiba, Wataru Nakata, Kosuke Nakano, Akira Nagahara, Kensaku Nishimura, Kazuo Nishimura

Int J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors.
Shotaro Sakka, Shuya Kandori, Koji Kawai, Takahiro Kojima, Satoshi Nitta, Kazuo Nishimura

Int J Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of bone metastasis in prostate cancer.
Kazuo Nishimura

J Bone Miner Metab· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
Makoto Ishii, Yoshiyuki Yamamoto, Akihiro Yoshimura, Takuji Hayashi, Norihiko Kawamura, Kazuo Nishimura

Hinyokika Kiyo· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma.
Noboru Nakaigawa, Yoshihiko Tomita, Satoshi Tamada, Katsunori Tatsugami, Takahiro Osawa, Kazuo Nishimura

Int J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL).
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Kazuo Nishimura

BMC Urol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study.
Yukio Kadokawa, Satoko Inoue, Akitoshi Tatsumi, Mayako Uchida, Keiko Fujita, Kazuo Nishimura

JGH Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer: A single-center study in Japan.
Yoshiyuki Yamamoto, Makoto Ishii, Akihiro Yoshimura, Takuji Hayashi, Norihiko Kawamura, Kazuo Nishimura

Int J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of financial toxicity with quality of life in testicular cancer survivors.
Kunihisa Nezu, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Kazuo Nishimura

Int J Urol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.
Tatsuya Nishikawa, Takako Inoue, Tomoyuki Otsuka, Ikumi Kuno, Yoji Kukita, Kazuo Nishimura

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis